<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39433700</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1559-0100</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>21</Day></PubDate></JournalIssue><Title>Endocrine</Title><ISOAbbreviation>Endocrine</ISOAbbreviation></Journal><ArticleTitle>COVID19 infection and vaccination and the risk of pituitary apoplexy: an entangled yarn.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12020-024-04078-7</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Pituitary apoplexy (PA) has been increasingly reported in association with both infection from and vaccination for COVID19. Our aim was to analyse the available published cases and compare the clinical characteristics in the two groups (infection vs vaccination).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We systematically reviewed the published literature for all cases of PA associated with COVID19 infection or vaccination. We also presented two cases managed at our Centre.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Collectively, fortythree cases were analysed. Patients with PA after COVID19 vaccination (n = 7), compared with patients with PA after COVID19 infection (n = 36), were significantly younger (p = 0.009) and had a more abrupt onset of PA (p = 0.022), but showed a milder hormonal involvement (p = 0.008) and a lower rate of persistent hypopituitarism during follow-up (p = 0.001). Patients in the vaccination group did not have clinical risk factors for PA, although this difference did not reach statistical significance.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">PA associated with COVID19 is a rare but clinically significant entity, although pathophysiological details of this association are lacking. Given the significantly different clinical presentation, we could speculate that PA induced by COVID19 vaccination might represent a distinct clinical entity, with different pathophysiological mechanism, compared to PA from COVID19 infection.</AbstractText><CopyrightInformation>© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ragni</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Endocrinology and Metabolic Diseases Unit, SS. Antonio e Biagio e Cesare Arrigo Teaching Hospital, Alessandria, Italy. alberto.ragni@ospedale.al.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biamonte</LastName><ForeName>Emilia</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Endocrinology and Metabolic Diseases Unit, SS. Antonio e Biagio e Cesare Arrigo Teaching Hospital, Alessandria, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cavigiolo</LastName><ForeName>Beatrice</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Endocrinology Unit, Maggiore della Carità Teaching Hospital, University of Eastern Piedmont, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mollero</LastName><ForeName>Edoardo Luigi Maria</ForeName><Initials>ELM</Initials><AffiliationInfo><Affiliation>Endocrinology Unit, Maggiore della Carità Teaching Hospital, University of Eastern Piedmont, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bendotti</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Endocrinology and Metabolic Diseases Unit, SS. Antonio e Biagio e Cesare Arrigo Teaching Hospital, Alessandria, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gabellieri</LastName><ForeName>Enrico</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Endocrinology and Metabolic Diseases Unit, SS. Antonio e Biagio e Cesare Arrigo Teaching Hospital, Alessandria, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leporati</LastName><ForeName>Paola</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Endocrinology and Metabolic Diseases Unit, SS. Antonio e Biagio e Cesare Arrigo Teaching Hospital, Alessandria, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gallo</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Endocrinology and Metabolic Diseases Unit, SS. Antonio e Biagio e Cesare Arrigo Teaching Hospital, Alessandria, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Endocrine</MedlineTA><NlmUniqueID>9434444</NlmUniqueID><ISSNLinking>1355-008X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID19</Keyword><Keyword MajorTopicYN="N">COVID19 vaccine</Keyword><Keyword MajorTopicYN="N">Hypophysis</Keyword><Keyword MajorTopicYN="N">Hypopituitarism</Keyword><Keyword MajorTopicYN="N">Pituitary gland</Keyword><Keyword MajorTopicYN="N">Transsphenoidal surgery</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>0</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>0</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>21</Day><Hour>23</Hour><Minute>21</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39433700</ArticleId><ArticleId IdType="doi">10.1007/s12020-024-04078-7</ArticleId><ArticleId IdType="pii">10.1007/s12020-024-04078-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Z.C. Hannoush, R.E. Weiss “Pituitary Apoplexy.,” In: Feingold K.R., Anawalt B., Blackman M.R., Boyce A., Chrousos G., Corpas E., de Herder W.W., Dhatariya K., Dungan K., Hofland J., et al., editors. Endotext. South Dartmouth [MA]: MDText.com, Inc. [2018] http://www.ncbi.nlm.nih.gov/books/NBK279125/ [Accessed June 22, 2024]</Citation></Reference><Reference><Citation>N. Muthukumar, Pituitary apoplexy: A comprehensive review. Neurol. India 68, S72–S78 (2020). https://doi.org/10.4103/0028-3886.287669</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0028-3886.287669</ArticleId><ArticleId IdType="pubmed">32611895</ArticleId></ArticleIdList></Reference><Reference><Citation>B. Biagetti, R. Simò, Pituitary apoplexy: Risk factors and underlying molecular mechanisms. Int. J. Mol. Sci. 23, 8721 (2022). https://doi.org/10.3390/ijms23158721</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23158721</ArticleId><ArticleId IdType="pubmed">35955859</ArticleId><ArticleId IdType="pmc">9369054</ArticleId></ArticleIdList></Reference><Reference><Citation>C. Hazzi, N. Villemure-Poliquin, S. Nadeau, P.-O. Champagne, SARS-CoV-2 infection, a risk factor for pituitary apoplexy? A case series and literature review. Ear Nose Throat J. 103, 153S–161S (2024). https://doi.org/10.1177/01455613231179714</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01455613231179714</ArticleId><ArticleId IdType="pubmed">37291861</ArticleId></ArticleIdList></Reference><Reference><Citation>K.A. Aghdam, Z.-A. Abtahi, S.A. Sonbolestan, M.S. Sanjari, Pituitary apoplexy secondary to thrombocytopenia due to severe acute respiratory syndrome coronavirus 2 infection: report of a rare case and literature review. J. Curr. Ophthalmol. 34, 364–368 (2022). https://doi.org/10.4103/joco.joco_321_21</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/joco.joco_321_21</ArticleId><ArticleId IdType="pubmed">36644472</ArticleId><ArticleId IdType="pmc">9832454</ArticleId></ArticleIdList></Reference><Reference><Citation>W.A. Kamel, M. Najibullah, M.S. Saleh, W.A. Azab, Coronavirus disease 2019 infection and pituitary apoplexy: A causal relation or just a coincidence? A case report and review of the literature. Surg. Neurol. Int 12, 317 (2021). https://doi.org/10.25259/SNI_401_2021</Citation><ArticleIdList><ArticleId IdType="doi">10.25259/SNI_401_2021</ArticleId><ArticleId IdType="pubmed">34345458</ArticleId><ArticleId IdType="pmc">8326077</ArticleId></ArticleIdList></Reference><Reference><Citation>R. Martinez-Perez, M.W. Kortz, B.W. Carroll, D. Duran, J.S. Neill, G.D. Luzardo, M.A. Zachariah, Coronavirus disease 2019 and pituitary apoplexy: A single-center case series and review of the literature. World Neurosurg. 152, e678–e687 (2021). https://doi.org/10.1016/j.wneu.2021.06.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.wneu.2021.06.004</ArticleId><ArticleId IdType="pubmed">34129968</ArticleId><ArticleId IdType="pmc">8196470</ArticleId></ArticleIdList></Reference><Reference><Citation>S. Rahman, M.T.V. Montero, K. Rowe, R. Kirton, F. Kunik, Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: a review of current evidence. Expert Rev. Clin. Pharm. 14, 601–621 (2021). https://doi.org/10.1080/17512433.2021.1902303</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17512433.2021.1902303</ArticleId></ArticleIdList></Reference><Reference><Citation>E.M. Conway, N. Mackman, R.Q. Warren, A.S. Wolberg, L.O. Mosnier, R.A. Campbell, L.E. Gralinski, M.T. Rondina, F.L. van de Veerdonk, K.M. Hoffmeister et al. Understanding COVID-19-associated coagulopathy. Nat. Rev. Immunol. 22, 639–649 (2022). https://doi.org/10.1038/s41577-022-00762-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-022-00762-9</ArticleId><ArticleId IdType="pubmed">35931818</ArticleId><ArticleId IdType="pmc">9362465</ArticleId></ArticleIdList></Reference><Reference><Citation>A. Bonaventura, A. Vecchié, L. Dagna, K. Martinod, D.L. Dixon, B.W. Van Tassell, F. Dentali, F. Montecucco, S. Massberg, M. Levi et al. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat. Rev. Immunol. 21, 319–329 (2021). https://doi.org/10.1038/s41577-021-00536-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00536-9</ArticleId><ArticleId IdType="pubmed">33824483</ArticleId><ArticleId IdType="pmc">8023349</ArticleId></ArticleIdList></Reference><Reference><Citation>L. Aliberti, I. Gagliardi, R. Rizzo, D. Bortolotti, G. Schiuma, P. Franceschetti, R. Gafà, L. Borgatti, M.A. Cavallo, M.C. Zatelli et al. Pituitary apoplexy and COVID-19 vaccination: a case report and literature review. Front Endocrinol. [Lausanne] 13, 1035482 (2022). https://doi.org/10.3389/fendo.2022.1035482</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2022.1035482</ArticleId></ArticleIdList></Reference><Reference><Citation>M. Verrienti, V. Marino Picciola, M.R. Ambrosio, M.C Zatelli, Pituitary and COVID-19 vaccination: a systematic review. Pituitary [2024] https://doi.org/10.1007/s11102-024-01402-2</Citation></Reference><Reference><Citation>A. Ragni, G. Bendotti, E. Biamonte, B. Cavigiolo, E. Gabellieri, P. Leporati, E.L.M. Mollero, M Gallo, SARS-Cov-2 infection: A new risk factor for pituitary apoplexy? Endocr. Metab. Immune Disord. Drug Targets [2024] https://doi.org/10.2174/0118715303315494240419060719</Citation></Reference><Reference><Citation>M.J. Page, J.E. McKenzie, P.M. Bossuyt, I. Boutron, T.C. Hoffmann, C.D. Mulrow, L. Shamseer, J.M. Tetzlaff, E.A. Akl, S.E. Brennan et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372, n71 (2021). https://doi.org/10.1136/bmj.n71</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId><ArticleId IdType="pmc">8005924</ArticleId></ArticleIdList></Reference><Reference><Citation>H. Tanaka, F. Nishimura, K. Nakase, S. Yokoyama, I. Nakagawa, S. Yamada, K. Tamura, R. Matsuda, Y. Takeshima, M. Kotsugi et al. Case report: Giant pituitary neuroendocrine tumor presented along with acute visual loss due to pituitary apoplexy after receiving COVID-19 vaccination. Front. Surg. 10, 1220098 (2023). https://doi.org/10.3389/fsurg.2023.1220098</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fsurg.2023.1220098</ArticleId><ArticleId IdType="pubmed">37576925</ArticleId><ArticleId IdType="pmc">10413133</ArticleId></ArticleIdList></Reference><Reference><Citation>N.A. Zainordin, S.F.W.M. Hatta, N. Ab Mumin, F.Z.M. Shah, R.A. Ghani, Pituitary apoplexy after COVID-19 vaccination: A case report. J. Clin. Transl. Endocrinol. Case Rep. 25, 100123 (2022). https://doi.org/10.1016/j.jecr.2022.100123</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jecr.2022.100123</ArticleId><ArticleId IdType="pubmed">35942396</ArticleId><ArticleId IdType="pmc">9351216</ArticleId></ArticleIdList></Reference><Reference><Citation>A. Piñar-Gutiérrez, P. Remón-Ruiz, A. Soto-Moreno, Case report: Pituitary apoplexy after COVID-19 vaccination. Med. Clin. [Engl. Ed.] 158, 498–499 (2022). https://doi.org/10.1016/j.medcle.2021.09.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medcle.2021.09.021</ArticleId></ArticleIdList></Reference><Reference><Citation>L. Roncati, A. Manenti, Pituitary apoplexy following adenoviral vector-based COVID-19 vaccination. Brain Hemorrhages 4, 27–29 (2023). https://doi.org/10.1016/j.hest.2022.04.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hest.2022.04.002</ArticleId><ArticleId IdType="pubmed">35464129</ArticleId></ArticleIdList></Reference><Reference><Citation>J. Shirin, A rare endocrine complication of the COVID-19 Vaccine. Endocr. Pract. 27, 116–117 (2021). https://doi.org/10.1016/j.eprac.2021.04.716</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eprac.2021.04.716</ArticleId></ArticleIdList></Reference><Reference><Citation>M.F. Yusof, J. Noor, Pituitary apoplexy with hypophysitis following ChAdOx1 nCoV-19 [AZD1222] vaccination: a potential culprit?</Citation></Reference><Reference><Citation>G. Racca, S. D’Agnano, N. Fasano, L. Gianotti, Pituitary apoplexy with transition to acute hypophysitis in a patient with Sars-CoV-2 Pneumonia. JCEM Case Rep. 1, luac010 (2023). https://doi.org/10.1210/jcemcr/luac010</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jcemcr/luac010</ArticleId><ArticleId IdType="pubmed">37908272</ArticleId></ArticleIdList></Reference><Reference><Citation>M. Corn, A. Nickell, C. Lessard, A. Jackson, Pituitary apoplexy during pregnancy with transsphenoidal resection and intraoperative fetal monitoring: A case report. Case Rep. Women’s. Health 39, e00543 (2023). https://doi.org/10.1016/j.crwh.2023.e00543</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.crwh.2023.e00543</ArticleId></ArticleIdList></Reference><Reference><Citation>H. Hussain, K. Janaka, D.T. Muthukuda, S.G. Perera, Pituitary apoplexy as a complication of COVID-19 infection. Cureus 15, e43524 (2023). https://doi.org/10.7759/cureus.43524</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.43524</ArticleId><ArticleId IdType="pubmed">37719628</ArticleId><ArticleId IdType="pmc">10500954</ArticleId></ArticleIdList></Reference><Reference><Citation>D. Popov, A. Hadzhiyanev, Pituitary apoplexy associated with COVID-19 infection: review and a case report. Biotechnol. Biotechnol. Equip. 36, 75–81 (2022). https://doi.org/10.1080/13102818.2022.2051738</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13102818.2022.2051738</ArticleId></ArticleIdList></Reference><Reference><Citation>Y. Yachou, A. El Idrissi, V. Belapasov, S. Ait Benali, Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients. Neurol. Sci. 41, 2657–2669 (2020). https://doi.org/10.1007/s10072-020-04575-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-020-04575-3</ArticleId><ArticleId IdType="pubmed">32725449</ArticleId><ArticleId IdType="pmc">7385206</ArticleId></ArticleIdList></Reference><Reference><Citation>A.M. Poma, A. Basolo, D. Bonuccelli, A. Toniolo, SARS-CoV-2 spread to endocrine organs is associated with obesity: an autopsy study of COVID-19 cases. Endocrine 83, 110–117 (2024). https://doi.org/10.1007/s12020-023-03518-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-023-03518-0</ArticleId><ArticleId IdType="pubmed">37698811</ArticleId></ArticleIdList></Reference><Reference><Citation>A. Greinacher, T. Thiele, T.E. Warkentin, K. Weisser, P.A. Kyrle, S. Eichinger, Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N. Engl. J. Med. 384, 2092–2101 (2021). https://doi.org/10.1056/NEJMoa2104840</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2104840</ArticleId><ArticleId IdType="pubmed">33835769</ArticleId></ArticleIdList></Reference><Reference><Citation>A. Gómez-Roldós, M. González-Sánchez, M. Vales-Montero, P. Vázquez-Alen, Y. Fernández-Bullido, A.M. Iglesias-Mohedano, F. Díaz-Otero, A. García-Pastor, A. Gil-Núñez, Fatal intracerebral haemorrhage associated with thrombosis with thrombocytopenia syndrome after ChAdOx1-S vaccine. Rev. Neurol. 75, 199–202 (2022). https://doi.org/10.33588/rn.7507.2021323</Citation><ArticleIdList><ArticleId IdType="doi">10.33588/rn.7507.2021323</ArticleId><ArticleId IdType="pubmed">36169326</ArticleId><ArticleId IdType="pmc">10280759</ArticleId></ArticleIdList></Reference><Reference><Citation>K.J. Welsh, J. Baumblatt, W. Chege, R. Goud, N. Nair, Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System [VAERS]. Vaccine 39, 3329–3332 (2021). https://doi.org/10.1016/j.vaccine.2021.04.054</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2021.04.054</ArticleId><ArticleId IdType="pubmed">34006408</ArticleId><ArticleId IdType="pmc">8086806</ArticleId></ArticleIdList></Reference><Reference><Citation>M. Goldman, C. Hermans, Thrombotic thrombocytopenia associated with COVID-19 infection or vaccination: Possible paths to platelet factor 4 autoimmunity. PLoS Med 18, e1003648 (2021). https://doi.org/10.1371/journal.pmed.1003648</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003648</ArticleId><ArticleId IdType="pubmed">34029337</ArticleId><ArticleId IdType="pmc">8153497</ArticleId></ArticleIdList></Reference><Reference><Citation>A. Vojdani, D. Kharrazian, Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases. Clin. Immunol. 217, 108480 (2020). https://doi.org/10.1016/j.clim.2020.108480</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2020.108480</ArticleId><ArticleId IdType="pubmed">32461193</ArticleId><ArticleId IdType="pmc">7246018</ArticleId></ArticleIdList></Reference><Reference><Citation>Y.T. Lawrence, L. Bacal, A. Krikorian, A novel association between pituitary tumor apoplexy and influenza A. AACE Clin. Case Rep. 2, 143–145 (2016). Doi:10.4158/EP15657.CR</Citation></Reference><Reference><Citation>H.S. Alyami, M.M. Al Wadany, A.S. Almousa, E.A. Khawaji, A.M. Almousa, M.A. Albaqshi, A.S. Alharbi, Pituitary apoplexy with pituitary macroadenoma in a patient with asymptomatic COVID-19: A case report. Cureus 14, e32810 (2022). https://doi.org/10.7759/cureus.32810</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.32810</ArticleId><ArticleId IdType="pubmed">36694516</ArticleId><ArticleId IdType="pmc">9860463</ArticleId></ArticleIdList></Reference><Reference><Citation>J. Balmain, M. Jarebi, A. Al-Salameh, P. Toussaint, M. Timmerman, L. Chenin, J.-M. Constans, R. Desailloud, Pituitary apoplexy in the aftermath of a SARS-CoV-2 infection: a case series from Amiens University Hospital. Eur. J. Endocrinol. 187, 19–25 (2022). https://doi.org/10.1530/EJE-22-0056</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EJE-22-0056</ArticleId></ArticleIdList></Reference><Reference><Citation>C. Taneja, P.K. Fazeli, P.A. Gardner, E.W. Wang, C.H. Snyderman, H. Mahmud, Rapidly progressive pituitary apoplexy in a patient with COVID-19 disease treated with endoscopic endonasal surgery. J. Neurol. Surg. Rep. 83, e8–e12 (2022). https://doi.org/10.1055/s-0041-1742104</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0041-1742104</ArticleId><ArticleId IdType="pubmed">35028278</ArticleId><ArticleId IdType="pmc">8747894</ArticleId></ArticleIdList></Reference><Reference><Citation>S.-Y. Liew, R. Seese, A. Shames, K. Majumdar, Apoplexy in a previously undiagnosed pituitary macroadenoma in the setting of recent COVID-19 infection. BMJ Case Rep. 14, e243607 (2021). https://doi.org/10.1136/bcr-2021-243607</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2021-243607</ArticleId><ArticleId IdType="pubmed">34321266</ArticleId><ArticleId IdType="pmc">8319972</ArticleId></ArticleIdList></Reference><Reference><Citation>S.J. Bordes, S. Phang-Lyn, E. Najera, H. Borghei-Razavi, B. Adada, Pituitary apoplexy attributed to COVID-19 infection in the absence of an underlying macroadenoma or other identifiable cause. Cureus 13, e13315 (2021). https://doi.org/10.7759/cureus.13315</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.13315</ArticleId><ArticleId IdType="pubmed">33732566</ArticleId><ArticleId IdType="pmc">7956048</ArticleId></ArticleIdList></Reference><Reference><Citation>V. Katti, L.B. Ramamurthy, S. Kanakpur, S.D. Shet, M. Dhoot, Neuro-ophthalmic presentation of COVID-19 disease: A case report. Indian J. Ophthalmol. 69, 992–994 (2021). https://doi.org/10.4103/ijo.IJO_3321_20</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ijo.IJO_3321_20</ArticleId><ArticleId IdType="pubmed">33727476</ArticleId><ArticleId IdType="pmc">8012961</ArticleId></ArticleIdList></Reference><Reference><Citation>M. LaRoy, M. McGuire, Pituitary apoplexy in the setting of COVID-19 infection. Am. J. Emerg. Med 47, 329.e1–329.e2 (2021). https://doi.org/10.1016/j.ajem.2021.02.045</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2021.02.045</ArticleId><ArticleId IdType="pubmed">33658149</ArticleId></ArticleIdList></Reference><Reference><Citation>R. Ghosh, D. Roy, D. Roy, A. Mandal, A. Dutta, D. Naga, J. Benito-León, A rare case of SARS-CoV-2 infection associated with pituitary apoplexy without comorbidities. J. Endocr. Soc. 5, bvaa203 (2021). https://doi.org/10.1210/jendso/bvaa203</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jendso/bvaa203</ArticleId><ArticleId IdType="pubmed">33501401</ArticleId><ArticleId IdType="pmc">7798947</ArticleId></ArticleIdList></Reference><Reference><Citation>S. Solorio-Pineda, C.A. Almendárez-Sánchez, A.A. Tafur-Grandett, G.A. Ramos-Martínez, R. Huato-Reyes, M.I. Ruiz-Flores, A. Sosa-Najera, Pituitary macroadenoma apoplexy in a severe acute respiratory syndrome-coronavirus-2-positive testing: Causal or casual? Surg. Neurol. Int 11, 304 (2020). https://doi.org/10.25259/SNI_305_2020</Citation><ArticleIdList><ArticleId IdType="doi">10.25259/SNI_305_2020</ArticleId><ArticleId IdType="pubmed">33093981</ArticleId><ArticleId IdType="pmc">7568102</ArticleId></ArticleIdList></Reference><Reference><Citation>J.L. Chan, K.D. Gregory, S.S. Smithson, M. Naqvi, A.N. Mamelak, Pituitary apoplexy associated with acute COVID-19 infection and pregnancy. Pituitary 23, 716–720 (2020). https://doi.org/10.1007/s11102-020-01080-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11102-020-01080-w</ArticleId><ArticleId IdType="pubmed">32915365</ArticleId><ArticleId IdType="pmc">7484495</ArticleId></ArticleIdList></Reference><Reference><Citation>V. Babu, J. Burks, S. Malik, K. Sapru, A rare case of pituitary apoplexy associated with COVID infection presenting with Central Diabetes Insipidus. Endocr. Pract. 28, 111 (2022). https://doi.org/10.1016/j.eprac.2022.03.263</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eprac.2022.03.263</ArticleId></ArticleIdList></Reference><Reference><Citation>N. Premarathna, A. Fernando, S. Bandusena, C. Lokubalasooriya, N. Vithanage, Covid 19 related acute necrotizing encephalopathy complicated with pituitary apoplexy. Neuroepidemiology [2022] 56: https://doi.org/10.1159/000523776</Citation></Reference><Reference><Citation>N. Mascarenhas, C.L. Alves, A. Campagnoli, D. Pedro, Pituitary apoplexy in a COVID-19 patient. Abstract Book, 17th. World Congr. Anaesthesiologists 133, 1–1973 (2021). https://doi.org/10.1213/01.ane.0000791544.44545.82</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/01.ane.0000791544.44545.82</ArticleId></ArticleIdList></Reference><Reference><Citation>C. Lesniak, K. Hu, M. Akula, K. Zin, R. Ong, S. Holland, J. Cheng, Pituitary apoplexy presenting in a COVID-19 positive patient as ophthalmoplegia. Endocr. Pract. 27, 115–116 (2021). https://doi.org/10.1016/j.eprac.2021.04.714</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eprac.2021.04.714</ArticleId></ArticleIdList></Reference><Reference><Citation>J.C. De La Flor Merino, L.M. Reyes, T. Linares Gravalos, A. Roel Conde, M. Rodeles del Pozo, An unusual case of severe acute hyponatremia in patient with COVID-19 infection. Nefrologia [Engl. Ed.] 40, 356–358 (2020). https://doi.org/10.1016/j.nefroe.2020.06.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nefroe.2020.06.015</ArticleId><ArticleId IdType="pubmed">32439187</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>